Anebulo Pharmaceuticals, Inc. (ANEB) Tops Q2 EPS by 8c

Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q2 EPS of ($0.05), $0.08 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.

You May Also Be Interested In

• Putin, Xi, Trump may hold trilateral talks at APEC summit - Russia's Vesti
• Meta: Muse voice transcribe available via Meta model API, Meta AI for Mac, Muse Code; API pricing : $3.00 per 1,000 audio-minutes
• U.S. forces began striking IRGC targets in Iran - Centcom